Getinge AB Company Description
Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments.
The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers extracorporeal membrane oxygenation, mechanical ventilation, mechanical circulatory support, advanced patient monitoring, ICU infrastructure equipment, patient flow management, and drainage solutions.
The company also provides surgical perfusion, endoscopic vessel harvesting, intra-aortic balloon counterpulsation, and drainage solutions; and operating room infrastructure equipment, anesthesia, advanced patient monitoring, operating room management, and operating room integration solutions.
In addition, it offers pre-cleaning, cleaning and disinfection, sterilization, consumables, endoscope reprocessing, and sterile supply management solutions; connected medical devices; bioreactor systems, DPTE systems, Getinge isolators, terminal sterilization products, and sterilizers; and vivarium, biohazardous materials handling solutions, labware cleaning and sterilization, upstream bioprocessing, and bioreactor preparation solutions.
It offers its products through a network of sales companies, as well as through agents and distributors in the Americas, Europe, the Middle East, Africa, and the Asia and Pacific.
Getinge AB (publ) was founded in 1904 and is headquartered in Gothenburg, Sweden.
![Getinge AB logo](https://img.stockanalysis.com/logos1/ST/GETI-B.png)
Country | Sweden |
Founded | 1904 |
Industry | Medical Devices |
Sector | Healthcare |
Employees | 11,891 |
CEO | Mattias Perjos |
Contact Details
Address: Lindholmspiren 7A Gothenburg, 417 56 Sweden | |
Phone | 46 1 03 35 00 00 |
Website | getinge.com |
Stock Details
Ticker Symbol | GETI.B |
Exchange | Nasdaq Stockholm |
Fiscal Year | January - December |
Reporting Currency | SEK |
ISIN Number | SE0000202624 |
SIC Code | 3845 |